Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
86 Results Found
Real-Time Supply Chain Strategies
Hospitals are using real-time supply chain strategies to meet the financial, operational and quality demands in the health care supply chain.
Tariff Implications for American Health Care
A series of tariffs recently implemented could have significant implications for health care.
AHA urges Department of Commerce to enact tariff exceptions for critical minerals used in medical devices
The AHA May 16 urged the Department of Commerce to consid
AHA Responds to Commerce Department Investigation of Critical Minerals
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on processed critical minerals and derivative products.
AHA urges Senate Finance Committee to strengthen supply chain
The AHA May 14 urged the Senate Finance Committee to take steps to strengthen the supply chain for essential pharmaceutical and other medical products.
AHA Senate Statement on Trade in Critical Supply Chains
AHA statement for the record to the Senate Committee on Finance regarding the importance of trade in critical supply chains.
Fact Sheet: Impact of Tariffs on Health Care Equipment
BackgroundHaving adequate and up-to-date medical supplies, devices and equipment
U.S., China temporarily agree to reduce tariffs for 90 days
The U.S. and China reached a joint agreement to temporarily reduce tariffs for 90 days, the White House announced May 12. Both countries will lower tariffs by 115% effective May 14.
AHA comments on national security investigation of pharmaceutical imports
AHA May 6 submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients imports.
AHA Comments on Commerce Department Investigation of Pharmaceutical Imports
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports.